<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000350223"><TermName>amonafide</TermName><TermPronunciation>(ay-MOH-nah-fide)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and intercalating agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730758" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;amonafide&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730759" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;amonafida&quot;" language="es" id="_4"/><SpanishTermName>amonafida</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de inhibidor de la topoisomerasa y un intercalante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-12-23</DateFirstPublished></GlossaryTerm>
